ASSESSMENT OF CIRCULATING MIRNAS AS POTENTIAL BIOMARKERS FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)

被引：0
|
作者：
Kirschner, M. B. [1 ]
Cheng, Y. Y. [1 ]
Badrian, B. [2 ]
Creaney, J. [3 ]
Edelman, J. J. [4 ]
Musk, A. W. [3 ]
Robinson, B. W. [3 ]
Klebe, S. [5 ,6 ]
van Zandwijk, N. [1 ]
Reid, G. [1 ]
机构：
[1] Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia
[2] Univ Western Australia, Lung Inst Western Australia, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Natl Res Ctr Asbestos Related Dis, Nedlands, WA 6009, Australia
[4] Univ Sydney, Royal Prince Alfred Hosp, Cardiothorac Surg Unit, Newtown, NSW, Australia
[5] Flinders Univ S Australia, Dept Anat Pathol, Bedford Pk, SA 5042, Australia
[6] Flinders Med Ctr, Bedford Pk, SA, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] Malignant pleural mesothelioma (MPM): analysis of consecutive 100 patients (pts)
    Abou-Elkasem, F
    Gaafar, R
    Abdelrahman, A
    Abdelbaki, H
    Hassan, N
    [J]. PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 107 - 112
  • [42] PET/CT in the preoperative evaluation of patients with malignant pleural mesothelioma (MPM)
    Gregianin, M.
    Rossi, F. Dei
    Cracco, E.
    Zaccaria, A.
    Canton, A.
    Pagan, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S142 - S142
  • [43] Initial analyses of the IASLC International Database for Malignant Pleural Mesothelioma (MPM)
    Rusch, Valerie W.
    Giroux, Dorothy
    Edwards, John
    Waller, David
    Kennedy, Catherine
    Ruffini, Enrico
    Pass, Harvey
    Rice, David
    Flores, Raja
    de Perrot, Marc
    Crowley, John
    Goldstraw, Peter
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S322 - S323
  • [44] Molecular Characterization of Malignant Pleural Mesothelioma (MPM) by next Generation Sequencing
    Cedres, Susana
    De Castro, Am Martinez
    Pardo, Nuria
    Navarro, Alejandro
    Martinez, Alex
    Amair, Fabiola
    Racca, Fabricio
    Scheenaard, Eulalia
    Recasens, Sergi
    De la Fuente, Iris
    Retter, Andrea
    Vilaro, Marta
    Vivancos, Ana
    Felip, Enriqueta
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1355 - S1356
  • [45] A Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
    Wozniak, A.
    Schneider, B.
    Kalemkerian, G.
    Daly, R.
    Chen, W.
    Ventimiglia, J.
    Nagasaka, M.
    Zauderer, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S343 - S343
  • [46] Malignant pleural mesothelioma (MPM): Trimodality therapy in a single center.
    Taverna, C
    Stahel, RA
    Bodis, S
    Russi, EW
    Weder, W
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 123 - 123
  • [47] Healthcare Professional Perceptions of Chemotherapy in Treatment of Malignant Pleural Mesothelioma (MPM)
    Kao, Steven
    Dhillon, Haryana
    Warby, Anne
    Vardy, Janette
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [48] Malignant pleural mesothelioma (MPM): Analysis of 78 consecutive patients (pts)
    Giovannini, Monica
    Terzi, Alberto
    Genestreti, Giovenzio
    Fiorio, Elena
    Lonardoni, Alessandro
    Falezza, Giovanni
    Magnanelli, Giovanni
    Maluta, Sergio
    Calabro, Francesco
    Cetto, Gian Luigi
    Santo, Antonio
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 25 - 26
  • [49] Combination efficacy of mTOR and MEK inhibitor in malignant pleural mesothelioma (MPM).
    Matsumoto, Seiji
    Orui, Hayato
    Kuroda, Ayumi
    Hashimoto, Masaki
    Yoneda, Kazue
    Takuwa, Teruhisa
    Kondo, Nobuyuki
    Hasegawa, Seiki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] First line chemotherapy with vinorelbine and cisplatin in malignant pleural mesothelioma (MPM)
    Sorensen, Jens B.
    Frank, Hanna
    Palshof, Torben
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 192 - 193
12345